Evelo Biosciences Chief Development Officer Jonathan Zung receives $4.6M in 2021
Evelo Biosciences reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
Evelo Biosciences reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, three executives at Evelo Biosciences received on average a compensation package of $4.2M, a 179% increase compared to previous year.
Average pay of disclosed executives at Evelo Biosciences
Jonathan Zung, Chief Development Officer, received $4.6M in total. 81% of Zung's compensation, or $3.7M, was in option awards. Zung also received $110K in bonus, $141K in non-equity incentive plan, $415K in salary, $167K in stock awards, as well as $47K in other compensation.
Balkrishan Simba Gill, Chief Executive Officer, received a compensation package of $4.2M, which increased by 94% compared to previous year. 80% of the compensation package, or $3.4M, was in option awards.
Luca Scavo, Chief Financial Officer, earned $3.9M in 2021.
Related executives
You may also like
Source: SEC filing on April 26, 2022.